Vascular Biogenics Ltd (VBLT) Reaches $6.26 After 6.00% Up Move; Bulldog Investors Increased Its Central Secs Com (CET) Holding

May 4, 2017 - By Ellis Scott

The stock of Vascular Biogenics Ltd (NASDAQ:VBLT) is a huge mover today! About 166,705 shares traded or 68.78% up from the average. Vascular Biogenics Ltd (NASDAQ:VBLT) has risen 7.14% since September 27, 2016 and is uptrending. It has underperformed by 3.42% the S&P500.The move comes after 7 months positive chart setup for the $172.71M company. It was reported on May, 4 by Barchart.com. We have $6.64 PT which if reached, will make NASDAQ:VBLT worth $10.36 million more.

Bulldog Investors Llc increased Central Secs Corp Com (CET) stake by 194.4% reported in 2016Q4 SEC filing. Bulldog Investors Llc acquired 267,576 shares as Central Secs Corp Com (CET)’s stock rose 2.78%. The Bulldog Investors Llc holds 405,221 shares with $5.58 million value, up from 137,645 last quarter. Central Secs Corp Com now has $606.89M valuation. The stock declined 0.04% or $0.01 reaching $24.5 on the news. About 9,784 shares traded. Central Securities Corp. (NYSEMKT:CET) has risen 16.49% since September 27, 2016 and is uptrending. It has outperformed by 5.93% the S&P500.

Investors sentiment increased to 2.89 in Q4 2016. Its up 1.39, from 1.5 in 2016Q3. It is positive, as 0 investors sold CET shares while 9 reduced holdings. 8 funds opened positions while 18 raised stakes. 2.55 million shares or 5.49% more from 2.42 million shares in 2016Q3 were reported. Da Davidson holds 0% or 70 shares in its portfolio. Bank Of Montreal Can stated it has 15,124 shares or 0% of all its holdings. Css Limited Liability Il holds 0.04% of its portfolio in Central Securities Corp. (NYSEMKT:CET) for 34,136 shares. 1607 Capital Prtnrs, a Virginia-based fund reported 162,850 shares. 192 were accumulated by Sei Invests. Brinker Inc reported 0.02% of its portfolio in Central Securities Corp. (NYSEMKT:CET). Financial Architects has invested 0.04% in Central Securities Corp. (NYSEMKT:CET). Stratos Wealth Prns invested 0.02% in Central Securities Corp. (NYSEMKT:CET). 237,677 are held by Gramercy Funds Mgmt Ltd Liability. Bulldog Limited Liability, New Jersey-based fund reported 405,221 shares. Moreover, Geode Cap Mgmt Limited Liability has 0% invested in Central Securities Corp. (NYSEMKT:CET). Wells Fargo And Mn holds 8,012 shares. Round Table Svcs Limited Co holds 11,919 shares or 0.11% of its portfolio. Thomas J Herzfeld Advsr owns 269,046 shares or 2.71% of their US portfolio. Fincl Bank Of America De invested in 0% or 11,339 shares.

Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company. The company has market cap of $172.71 million. The Firm is focused on the discovery, development and commercialization of treatments for cancer. It currently has negative earnings. The Company’s program is based on its Vascular Targeting System platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels.